Aradigm Corp. Company Profile (NASDAQ:ARDM)

About Aradigm Corp.

Aradigm Corp. logoAradigm Corporation is a pharmaceutical company focused on the development and commercialization of products for the treatment and prevention of severe respiratory diseases. The Company's lead product candidate is Pulmaquin inhaled ciprofloxacin, which is in Phase III clinical trials. It offers AERx pulmonary drug delivery platform and other technologies. Its partnered programs under development include Inhaled Ciprofloxacin. It is also engaged in developing Smoking Cessation Therapy (ARD-1600 Inhaled Nicotine). Its lead development candidates are its formulations of the potent antibiotic ciprofloxacin (Pulmaquin (ARD-3150) and Lipoquin (ARD-3100)) that are delivered by inhalation for the management of infections associated with the severe respiratory diseases, such as cystic fibrosis (CF) and non-cystic fibrosis bronchiectasis (BE). Pulmaquin uses slow release liposomal formulation (Lipoquin) mixed with a small amount of ciprofloxacin dissolved in an aqueous medium.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Drug Delivery
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: ARDM
  • CUSIP:
Key Metrics:
  • Previous Close: $6.25
  • 50 Day Moving Average: $4.77
  • 200 Day Moving Average: $4.52
  • 52-Week Range: $14,781,000.00 - $2.60
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -3.53
  • P/E Growth: 0.00
  • Market Cap: $96.08M
  • Outstanding Shares: 14,781,000
  • Beta: 0.9
Profitability:
  • Net Margins: -670.67%
  • Return on Equity: -147.53%
  • Return on Assets: -88.51%
Debt:
  • Debt-to-Equity Ratio: 0.66%
  • Current Ratio: 6.85%
  • Quick Ratio: 6.85%
Additional Links:
Companies Related to Aradigm Corp.:

Analyst Ratings

Consensus Ratings for Aradigm Corp. (NASDAQ:ARDM) (?)
Ratings Breakdown: No ratings tracked in the last 12 months.
Consensus Rating:N/A (Score: NaN)
Consensus Price Target: N/A

Analysts' Ratings History for Aradigm Corp. (NASDAQ:ARDM)
Show:
No equities research coverage for this company has been tracked by MarketBeat.com

Earnings

Earnings History for Aradigm Corp. (NASDAQ:ARDM)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
11/9/2016        
8/10/2016Q2($0.59)($0.59)ViewN/AView Earnings Details
5/10/2016Q1($0.59)($0.55)ViewN/AView Earnings Details
3/15/2016Q415($0.55)($0.63)ViewN/AView Earnings Details
11/11/2015Q3($0.19)($0.38)ViewN/AView Earnings Details
8/13/2015Q2($0.08)($0.08)$11.60 million$10.00 millionViewN/AView Earnings Details
5/11/2015Q1($0.06)($0.08)ViewN/AView Earnings Details
3/17/2015Q414($0.07)($0.06)$6.70 million$8.10 millionViewN/AView Earnings Details
11/7/2014Q314($0.10)($0.06)$4.80 million$6.60 millionViewN/AView Earnings Details
8/7/2014Q214($0.09)($0.09)$4.25 million$12.20 millionViewN/AView Earnings Details
10/28/2013Q3 13($0.04)ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Aradigm Corp. (NASDAQ:ARDM)
Current Year EPS Consensus Estimate: $-1.92 EPS
Next Year EPS Consensus Estimate: $-1.84 EPS

Dividends

Dividend History for Aradigm Corp. (NASDAQ:ARDM)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Aradigm Corp. (NASDAQ:ARDM)
Insider Ownership Percentage: 4.10%
Institutional Ownership Percentage: 44.27%
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
6/21/2016Juergen Kurt FroehlichInsiderSell333$4.45$1,481.85View SEC Filing  
12/13/2013Virgil ThompsonDirectorSell3,340$0.17$567.80View SEC Filing  
8/27/2013First Eagle Investment ManagemMajor ShareholderBuy40,322,580$0.12$4,838,709.60View SEC Filing  
12/11/2012First Eagle Investment ManagemMajor ShareholderBuy41,666,667$0.12$5,000,000.04View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Aradigm Corp. (NASDAQ:ARDM)
DateHeadline
News IconAradigm Corporation Announces the Dosing of the First Patient in Phase III Study of Pulmaquin in Non-Cystic Fibrosis Bronchiectasis (ORBIT-3) (NASDAQ:ARDM)
www.pharmiweb.com - September 24 at 8:51 AM
fxpips.com logoManufacturing Stocks Review – Winners and Losers (NASDAQ:ARDM)
www.fxpips.com - September 23 at 8:24 AM
rttnews.com logoARDM Awaits Data In Q4, FDA Clears TCMD Device, Newfound Interest For GLMD, GALT (NASDAQ:ARDM)
www.rttnews.com - September 23 at 8:24 AM
finance.yahoo.com logo3 Reasons Why Aradigm Corporation (ARDM) is a Great Momentum Stock (NASDAQ:ARDM)
finance.yahoo.com - September 22 at 3:31 PM
News IconAradigm Announces Last Patient Dosing Visit in ORBIT-3 and ORBIT-4 Phase 3 Studies of Pulmaquin ... (NASDAQ:ARDM)
www.biomedreports.com - September 22 at 9:26 AM
News IconAradigm Corporation To Present At The 2016 Healthcare Conference On September 27 (NASDAQ:ARDM)
www.biospace.com - September 22 at 9:26 AM
nasdaq.com logoAradigm (ARDM) Shares March Higher, Can It Continue? (NASDAQ:ARDM)
www.nasdaq.com - September 22 at 9:26 AM
News IconAradigm Announces Last Patient Dosing Visit in ORBIT-3 & ORBIT-4 Phase 3 Studies of Pulmaquin in Non-Cystic Fibrosis Bronchie... (NASDAQ:ARDM)
www.advfn.com - September 22 at 9:26 AM
publicnow.com logoAradigm Announces Last Patient Dosing Visit in ORBIT-3 and ORBIT-4 Phase 3 Studies of Pulmaquin in Non-Cystic Fibrosis Bronchiectasis Patients (NASDAQ:ARDM)
www.publicnow.com - September 22 at 9:26 AM
publicnow.com logoAradigm to Host Analyst Meeting and Webcast on September 26 in New York City (NASDAQ:ARDM)
www.publicnow.com - September 21 at 8:49 AM
finance.yahoo.com logoAradigm to Present at the Ladenburg Thalmann 2016 Healthcare Conference on September 27 (NASDAQ:ARDM)
finance.yahoo.com - September 20 at 9:29 AM
News IconAradigm Corporation (ARDM) - Medical Equipment - Deals and Alliances Profile - New Market Report (NASDAQ:ARDM)
reports.pr-inside.com - September 16 at 3:32 PM
News IconNewly released market study: Stille AB (STIL) - Medical Equipment - Deals and Alliances Profile (NASDAQ:ARDM)
reports.pr-inside.com - September 15 at 12:28 PM
capitalcube.com logoAradigm Corp. :ARDM-US: Earnings Analysis: Q2, 2016 By the Numbers : August 12, 2016 (NASDAQ:ARDM)
www.capitalcube.com - August 12 at 12:07 PM
sg.finance.yahoo.com logoAradigm reports 2Q loss (NASDAQ:ARDM)
sg.finance.yahoo.com - August 10 at 9:40 AM
publicnow.com logoAradigm Announces Second Quarter 2016 Financial Results (NASDAQ:ARDM)
www.publicnow.com - August 10 at 9:40 AM
biz.yahoo.com logoARADIGM CORP Files SEC form 8-K, Submission of Matters to a Vote of Security Holders (NASDAQ:ARDM)
biz.yahoo.com - June 10 at 5:02 PM
capitalcube.com logoAradigm Corp. :ARDM-US: Earnings Analysis: Q1, 2016 By the Numbers (NASDAQ:ARDM)
www.capitalcube.com - May 17 at 12:15 PM
publicnow.com logoTwo Presentations on Aradigm's Inhaled Liposomal Ciprofloxacin Programs at the American Thoracic Society 2016 International Conference (NASDAQ:ARDM)
www.publicnow.com - May 11 at 7:22 AM
finance.yahoo.com logoTwo Presentations on Aradigm’s Inhaled Liposomal Ciprofloxacin Programs at the American Thoracic Society 2016 International Conference (NASDAQ:ARDM)
finance.yahoo.com - May 11 at 7:00 AM
sg.finance.yahoo.com logoAradigm reports 1Q loss (NASDAQ:ARDM)
sg.finance.yahoo.com - May 10 at 9:03 AM
publicnow.com logoAradigm Announces First Quarter 2016 Financial Results (NASDAQ:ARDM)
www.publicnow.com - May 10 at 7:08 AM
insidermonkey.com logoActivist Starboard Value Gets Seats on Marvell Technology Group Ltd. (MRVL)’s Board; Two Other Hedge Funds Disclose Latest Moves (NASDAQ:ARDM)
www.insidermonkey.com - April 29 at 9:42 AM
biz.yahoo.com logoARADIGM CORP Files SEC form 8-K/A, Financial Statements and Exhibits (NASDAQ:ARDM)
biz.yahoo.com - April 28 at 4:08 PM
biz.yahoo.com logoARADIGM CORP Files SEC form 8-K, Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligatio (NASDAQ:ARDM)
biz.yahoo.com - April 27 at 4:30 PM
publicnow.com logoAradigm Corporation Announces First Closing of Private Placement Offering of $23 Million Senior Convertible Notes Due 2021 (NASDAQ:ARDM)
www.publicnow.com - April 26 at 7:26 AM
biz.yahoo.com logoARADIGM CORP Files SEC form 8-K, Financial Statements and Exhibits (NASDAQ:ARDM)
biz.yahoo.com - April 25 at 12:08 PM
proactiveinvestors.co.uk logoSlew of results disappointments hamstring S&P (NASDAQ:ARDM)
www.proactiveinvestors.co.uk - April 23 at 6:45 AM
publicnow.com logoAradigm Corporation Prices Private Placement of Senior Notes (NASDAQ:ARDM)
www.publicnow.com - April 22 at 8:36 AM
biz.yahoo.com logoARADIGM CORP Files SEC form 10-K, Annual Report (NASDAQ:ARDM)
biz.yahoo.com - March 30 at 2:33 PM
finance.yahoo.com logo7:00 am Aradigm announces that the EMA has approved its request to review Pulmaquin under the Centralised Authorisation Procedure drug review process (NASDAQ:ARDM)
finance.yahoo.com - March 17 at 7:00 AM
finance.yahoo.com logoAradigm Announces Decision for Centralized Review of Pulmaquin by the European Medicines Agency (NASDAQ:ARDM)
finance.yahoo.com - March 17 at 7:00 AM
sg.finance.yahoo.com logoAradigm reports 4Q loss (NASDAQ:ARDM)
sg.finance.yahoo.com - March 15 at 7:13 AM
finance.yahoo.com logoAradigm Announces Fourth Quarter 2015 and Full Year Financial Results (NASDAQ:ARDM)
finance.yahoo.com - March 15 at 7:00 AM
finance.yahoo.com logoAradigm to Present at the Biotechnology Industry Organization (BIO) CEO & Investor Conference 2016 on February 8 (NASDAQ:ARDM)
finance.yahoo.com - February 2 at 7:00 AM
noodls.com logoAradigm to Host Corporate Update Conference Call on January 6 (NASDAQ:ARDM)
www.noodls.com - January 5 at 7:28 AM
capitalcube.com logoAradigm Corp.: Sudden move in price, will it continue? (NASDAQ:ARDM)
www.capitalcube.com - December 23 at 5:16 PM
capitalcube.com logoAradigm Corp. Earnings Analysis: Q3, 2015 By the Numbers (NASDAQ:ARDM)
www.capitalcube.com - December 21 at 12:11 PM
finance.yahoo.com logoARADIGM CORP Financials (NASDAQ:ARDM)
finance.yahoo.com - December 8 at 1:17 PM
finance.yahoo.com logoHow it All Plays Out - Research on Aradigm, Ideal Power, CareDx, and Colony Bankcorp (NASDAQ:ARDM)
finance.yahoo.com - December 3 at 8:40 AM
biz.yahoo.com logoARADIGM CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits (NASDAQ:ARDM)
biz.yahoo.com - November 12 at 3:20 PM
biz.yahoo.com logoARADIGM CORP Files SEC form 10-Q, Quarterly Report (NASDAQ:ARDM)
biz.yahoo.com - November 12 at 6:12 AM
noodls.com logoAradigm Announces Third Quarter 2015 Financial Results (NASDAQ:ARDM)
www.noodls.com - November 11 at 7:16 AM
sg.finance.yahoo.com logoAradigm reports 3Q loss (NASDAQ:ARDM)
sg.finance.yahoo.com - November 11 at 7:06 AM
capitalcube.com logoAradigm Corp. – Value Analysis (NASDAQ:ARDM) : October 30, 2015 (NASDAQ:ARDM)
www.capitalcube.com - October 30 at 3:19 PM
finance.yahoo.com logoAradigm Corporation Completes Enrollment in the Second Phase III Study of Pulmaquin in Non-Cystic Fibrosis Bronchiectasis (ORBIT-3) (NASDAQ:ARDM)
finance.yahoo.com - October 13 at 7:00 AM
noodls.com logoAradigm to Present at the Ladenburg Thalmann 2015 Healthcare Conference on September 29 (NASDAQ:ARDM)
www.noodls.com - September 23 at 7:25 AM

Social

Aradigm Corp. (NASDAQ:ARDM) Chart for Sunday, September, 25, 2016


Last Updated on 9/25/2016 by MarketBeat.com Staff